Familial Transthyretin Amyloid Cardiomyopathy
📧 Sign up to get email alerts when something new happens for Familial Transthyretin Amyloid Cardiomyopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: ENDEAVOUR: Phase 3 Multicenter Study of Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) [Phase 3]
Phase 3 ENDEAVOUR trial evaluating Revusiran (ALN-TTRSC) in transthyretin-mediated familial amyloid cardiomyopathy has completed with result…